USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $-0.29 | $-0.27 | $-0.37 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $3.39M | $1.86M | $278.00K |
Evofem Biosciences's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 4 | $-0.35 | $-0.56 | $-0.26 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 4 | $-1.39 | $-1.61 | $-1.24 |
| Dec 2022 | 4 | $-0.72 | $-0.92 | $-0.50 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 1 | $-0.38 | $-0.34 | $-0.38 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 1 / 0 | $-1.45 | $-1.41 | $-1.65 |
| Dec 2022 | 1 / 0 | $-0.80 | $-0.78 | $-0.96 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Dec 2021 | 3 | $5.76M | $3.60M | $8.28M |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 4 | $11.39M | $8.81M | $15.85M |
| Dec 2022 | 4 | $50.13M | $28.16M | $79.28M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $-0.29 | - | - |
| Aug 11, 2021 | Jun 2021 | $-0.35 | $-0.27 | 23.40% |
| May 6, 2021 | Mar 2021 | $-0.49 | $-0.56 | -14.87% |
| Mar 4, 2021 | Dec 2020 | $-0.36 | $-0.49 | -35.17% |
| Nov 9, 2020 | Sep 2020 | $-0.44 | $-0.37 | 15.91% |
| Aug 4, 2020 | Jun 2020 | $-0.37 | $-0.91 | -143.77% |
| May 6, 2020 | Mar 2020 | $-0.35 | $-0.40 | -15.37% |
| Mar 12, 2020 | Dec 2019 | $-0.30 | $-0.27 | 10.00% |
| Nov 6, 2019 | Sep 2019 | $-0.31 | $-0.30 | 2.44% |
| Aug 6, 2019 | Jun 2019 | $-0.36 | $-0.97 | -169.44% |
| May 7, 2019 | Mar 2019 | $-0.44 | $-0.67 | -52.27% |
| Mar 1, 2019 | Dec 2018 | $-0.55 | $-0.58 | -5.45% |
| Nov 7, 2018 | Sep 2018 | $-0.42 | $-0.71 | -69.05% |
| Aug 2, 2018 | Jun 2018 | $-0.48 | $-1.11 | -132.46% |
| May 14, 2018 | Mar 2018 | $-0.41 | $-1.42 | -245.34% |
| Feb 26, 2018 | Dec 2017 | $-1.14 | $-1.02 | 10.32% |
| Nov 8, 2017 | Sep 2017 | - | $-0.78 | - |
| Aug 10, 2017 | Jun 2017 | - | $-1.22 | - |
| May 11, 2017 | Mar 2017 | $-1.14 | $-1.32 | -15.79% |
| Mar 23, 2017 | Dec 2016 | $-1.20 | $-0.84 | 30.00% |
| Nov 10, 2016 | Sep 2016 | $-1.86 | $-1.02 | 45.16% |
| Aug 11, 2016 | Jun 2016 | $-2.40 | $-1.14 | 52.50% |
| May 12, 2016 | Mar 2016 | - | $-2.63 | - |
| Mar 29, 2016 | Dec 2015 | $-1.14 | $-0.69 | 39.47% |
| Nov 12, 2015 | Sep 2015 | $-1.14 | $-1.26 | -10.53% |
| Aug 13, 2015 | Jun 2015 | $-1.14 | $-0.69 | 39.47% |
| May 14, 2015 | Mar 2015 | $-0.93 | $-0.50 | 46.24% |
| Mar 26, 2015 | Dec 2014 | $-0.32 | $-0.45 | -40.63% |
| Dec 1, 2014 | Sep 2014 | - | $-1.69 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 4, 2021 | Dec 2020 | $-1.93 | $-2.17 | - |
| Mar 12, 2020 | Dec 2019 | $-1.99 | $-2.21 | - |
| Mar 1, 2019 | Dec 2018 | $-5.81 | $-3.82 | - |
| Feb 26, 2018 | Dec 2017 | $0.00 | $-4.35 | - |
| Mar 23, 2017 | Dec 2016 | - | $-5.63 | - |
| Mar 29, 2016 | Dec 2015 | - | $-3.14 | - |
| Mar 26, 2015 | Dec 2014 | - | $-2.14 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $3.39M | - | - |
| Aug 11, 2021 | Jun 2021 | $2.68M | $1.86M | 0.69% |
| May 6, 2021 | Mar 2021 | $1.63M | $1.10M | 0.68% |
| Mar 4, 2021 | Dec 2020 | $1.69M | $168.00K | 0.10% |
| Nov 9, 2020 | Sep 2020 | $1.72M | $278.00K | 0.16% |
| Aug 4, 2020 | Jun 2020 | $0.00 | $0.00 | - |
| May 6, 2020 | Mar 2020 | $0.00 | $0.00 | - |
| Mar 12, 2020 | Dec 2019 | $0.00 | $0.00 | - |
| Nov 6, 2019 | Sep 2019 | $0.00 | $0.00 | - |
| Aug 6, 2019 | Jun 2019 | $0.00 | $0.00 | - |
| May 7, 2019 | Mar 2019 | $0.00 | $0.00 | - |
| Mar 1, 2019 | Dec 2018 | $0.00 | $0.00 | - |
| Nov 7, 2018 | Sep 2018 | $0.00 | $0.00 | - |
| Aug 2, 2018 | Jun 2018 | $0.00 | $0.00 | - |
| May 14, 2018 | Mar 2018 | - | $0.00 | - |
| Feb 26, 2018 | Dec 2017 | - | $0.00 | - |
| Nov 8, 2017 | Sep 2017 | $0.00 | $0.00 | - |
| Aug 10, 2017 | Jun 2017 | $0.00 | $0.00 | - |
| May 11, 2017 | Mar 2017 | - | $0.00 | - |
| Mar 23, 2017 | Dec 2016 | - | $0.00 | - |
| Nov 10, 2016 | Sep 2016 | - | $0.00 | - |
| Aug 11, 2016 | Jun 2016 | - | $0.00 | - |
| May 12, 2016 | Mar 2016 | - | $0.00 | - |
| Mar 29, 2016 | Dec 2015 | - | $0.00 | - |
| Nov 12, 2015 | Sep 2015 | - | $0.00 | - |
| Aug 13, 2015 | Jun 2015 | - | $0.00 | - |
| May 14, 2015 | Mar 2015 | - | $0.00 | - |
| Mar 26, 2015 | Dec 2014 | - | - | - |
| Dec 1, 2014 | Sep 2014 | - | - | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 4, 2021 | Dec 2020 | $1.80M | $446.00K | -75.22% |
| Mar 12, 2020 | Dec 2019 | $0.00 | $0.00 | - |
| Mar 1, 2019 | Dec 2018 | $0.00 | $0.00 | - |
| Feb 26, 2018 | Dec 2017 | $0.00 | $0.00 | - |
| Mar 23, 2017 | Dec 2016 | - | $0.00 | - |
| Mar 29, 2016 | Dec 2015 | - | $0.00 | - |
| Mar 26, 2015 | Dec 2014 | - | - | - |
EVFM's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 30, 2021.
According to 4 analysts, the average EPS estimation for Evofem Biosciences's next quarterly earnings is $-0.29, with a low EPS estimation of $-0.33, and a high estimation of $-0.26.
Over the last 1 month, EPS estimates have seen 1 upward revisions and 0 downward. The EPS 1 month trend is $-0.31, the last 2 month trend is $-0.30, and the 3 month trend is $-0.38.
Based on 2 analysts, the average revenue estimation is $3.39M, with a low revenue estimation of $2.25M, and a high estimation of $4.61M.
Evofem Biosciences's previous earnings date was Aug 11, 2021 for its fiscal quarter ended Jun 30, 2021.
EVFM's earnings per share (EPS) was $-0.27, beating the consensus analysts forecast of $-0.35 by 23.40%.
The EPS was higher than the previous fiscal quarter (Mar 2021) by -51.79%, and higher than the same period a year before (Jun 2020) by -70.33%.
Revenues were $1.86M.
The company reported a net income of $-33.43M.Free cash flow for the quarter was $-54.91M , compared to $-35.41M last quarter and $-15.49M a year before.
EVFM ended the quarter with $78.14M in total debt, a decrease of -10.15% compared to the previous quarter, and an increase of 57.69% compared to the same quarter a year before.
Evofem Biosciences's previous annual earnings date was Mar 4, 2021 for its fiscal year ended Dec 31, 2020.
EVFM's earnings per share (EPS) was $-2.17, missing the consensus analysts forecast of $-1.93 by 12.44% , and higher than the previous year's EPS (Dec 2019) by -1.81%.
Revenues were $446.00K.
The company reported a net income of $-142.31M.
Evofem Biosciences reported a free cash flow of $-107.08M for its fiscal year, compared to $-55.26M a year ago.
The company ended the fiscal year with $79.91M in total debt, an increase of 40463.45% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.